The new software could be rolled out to surgeries across the UK from next year.
The electronic Cancer Decision Support programme trial was presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool; it can estimate cancer risk for oesophago-gastric, lung, colorectal, pancreatic and ovarian cancers, based on the patterns of presenting symptoms researchers said.
Macmillan Cancer Support, the charity behind the work partly funded by the Department of Health, hopes the programme could be rolled out to surgeries across the UK from next year.
Target Ovarian Cancer’s Director of Public Affairs and Services, Frances Reid, said: “The Macmillan team are very positive about the potential of the programme to prompt GPs to investigate suspicious symptoms of ovarian cancer. The trial concludes this month, and we are looking forward to the preliminary results which are expected early next year. Ovarian cancer is a challenging disease to diagnose, and anything which ensures women with symptoms are investigated promptly and appropriately is to be welcomed. “
Target Ovarian Cancer and Macmillan Cancer Support recently collaborated to produce a series of ‘10 Top Tips’ which aim to support patients and GPs in communicating more effectively with each other about the symptoms of ovarian cancer.
Target Ovarian Cancer also provides free to access online continuing professional development for GPs, produced with both BMJ Learning and the Royal College of GPs. These have now been completed by over 9,000 GPs.